However, univariate and multivariate analysis showed that lung metastasis as the first metastatic event (OR 2.168, 95% CI: 1.099 to 4.274) was the independent risk factor for BM in HER2-positive BC patients in our study. Here, ERBB2 is linked to breast cancer.